{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:32:39Z","timestamp":1793845959430,"version":"4.6.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T00:00:00Z","timestamp":1610755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T00:00:00Z","timestamp":1610755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00125-020-05354-7","type":"journal-article","created":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T08:02:42Z","timestamp":1610784162000},"page":"978-984","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Minimising hypoglycaemia in the real world: the challenge of\n            insulin"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4055-5233","authenticated-orcid":false,"given":"Chantal","family":"Mathieu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,16]]},"reference":[{"key":"5354_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","volume":"383","author":"MA Atkinson","year":"2014","unstructured":"Atkinson MA, Eisenbarth GS, Michels AW (2014) Type 1 diabetes.\n                    Lancet 383:69\u201382. https:\/\/doi.org\/10.1016\/S0140-6736(13)60591-7","journal-title":"Lancet"},{"issue":"1084","key":"5354_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/postgradmedj-2015-133281","volume":"92","author":"F Zaccardi","year":"2016","unstructured":"Zaccardi F, Webb DR, Yates T, Davies MJ (2016) Pathophysiology of\n                    type 1 and type 2 diabetes mellitus: a 90-year perspective. Postgrad Med J\n                    92(1084):63\u201369. https:\/\/doi.org\/10.1136\/postgradmedj-2015-133281","journal-title":"Postgrad Med J"},{"key":"5354_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-016-4146-6","volume":"60","author":"International Hypoglycaemia Study Group","year":"2017","unstructured":"International Hypoglycaemia Study Group (2017) Glucose\n                    concentrations of less than 3.0 mmol\/L (54 mg\/dL) should be reported in clinical\n                    trials: a joint position statement of the American Diabetes Association and the\n                    European Association for the Study of Diabetes. Diabetologia 60:3\u20136. https:\/\/doi.org\/10.1007\/s00125-016-4146-6","journal-title":"Diabetologia"},{"issue":"8","key":"5354_CR4","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM et al (2019) Clinical targets\n                    for continuous glucose monitoring data interpretation: recommendations from the\n                    international consensus on time in range. Diabetes Care 42(8):1593\u20131603. https:\/\/doi.org\/10.2337\/dci19-0028","journal-title":"Diabetes Care"},{"issue":"2","key":"5354_CR5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2337\/dc19-1610","volume":"43","author":"S Charleer","year":"2020","unstructured":"Charleer S, De Block C, Van Huffel L et al (2020) Quality of life\n                    and glucose control after 1 year of nationwide reimbursement of intermittently\n                    scanned continuous glucose monitoring in adults living with type 1 diabetes\n                    (FUTURE): a prospective observational real-world cohort study. Diabetes Care\n                    43(2):389\u2013397. https:\/\/doi.org\/10.2337\/dc19-1610","journal-title":"Diabetes Care"},{"issue":"12","key":"5354_CR6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nrendo.2014.170","volume":"10","author":"BM Frier","year":"2014","unstructured":"Frier BM (2014) Hypoglycaemia in diabetes mellitus: epidemiology\n                    and clinical implications. Nat Rev Endocrinol 10(12):711\u2013722. https:\/\/doi.org\/10.1038\/nrendo.2014.170","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"5354_CR7","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.jval.2013.09.002","volume":"16","author":"M Brod","year":"2013","unstructured":"Brod M, Wolden M, Christensen T, Bushnell DM (2013) Understanding\n                    the economic burden of nonsevere nocturnal hypoglycemic events: impact on work\n                    productivity, disease management, and resource utilization. Value Health\n                    16(8):1140\u20131149. https:\/\/doi.org\/10.1016\/j.jval.2013.09.002","journal-title":"Value Health"},{"issue":"9","key":"5354_CR8","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1185\/030079905X61929","volume":"21","author":"RE Davis","year":"2005","unstructured":"Davis RE, Morrissey M, Peters JR, Wittrup-Jensen K, Kennedy-Martin\n                    T, Currie CJ (2005) Impact of hypoglycaemia on quality of life and productivity\n                    in type 1 and type 2 diabetes. Curr Med Res Opin 21(9):1477\u20131483. https:\/\/doi.org\/10.1185\/030079905X61929","journal-title":"Curr Med Res Opin"},{"key":"5354_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.diabres.2017.05.004","volume":"130","author":"K Khunti","year":"2017","unstructured":"Khunti K, Alsifri S, Aronson R et al (2017) Impact of hypoglycaemia\n                    on patient-reported outcomes from a global, 24-country study of 27,585 people\n                    with type 1 and insulin-treated type 2 diabetes. Diabetes Res Clin Pract\n                    130:121\u2013129. https:\/\/doi.org\/10.1016\/j.diabres.2017.05.004","journal-title":"Diabetes Res Clin Pract"},{"key":"5354_CR10","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.2337\/dc15-0102","volume":"38","author":"E Yeoh","year":"2015","unstructured":"Yeoh E, Choudhary P, Nwokolo M, Ayis S, Amiel SA (2015)\n                    Interventions that restore awareness of hypoglycemia in adults with type 1\n                    diabetes: a systematic review and meta-analysis. Diabetes Care 38:1592\u20131609. https:\/\/doi.org\/10.2337\/dc15-0102","journal-title":"Diabetes Care"},{"issue":"7","key":"5354_CR11","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrendo.2017.39","volume":"13","author":"C Mathieu","year":"2017","unstructured":"Mathieu C, Gillard P, Benhalima K (2017) Insulin analogues in type\n                    1 diabetes: getting better all the time. Nat Rev Endocrinol 13(7):385\u2013399. https:\/\/doi.org\/10.1038\/nrendo.2017.39","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"5354_CR12","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/pedi.12888","volume":"20","author":"AL Brorsson","year":"2019","unstructured":"Brorsson AL, Leksell J, Andersson Franko M, Lindholm Olinder A\n                    (2019) A person-centered education for adolescents with type 1 diabetes-a\n                    randomized controlled trial. Pediatr Diabetes 20(7):986\u2013996. https:\/\/doi.org\/10.1111\/pedi.12888","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"5354_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00592-017-1070-2","volume":"55","author":"N Kuniss","year":"2018","unstructured":"Kuniss N, M\u00fcller UA, Kloos C et al (2018) Substantial improvement\n                    in HbA1c following a treatment and teaching programme for people with type 2\n                    diabetes on conventional insulin therapy in an in- and outpatient setting. Acta\n                    Diabetol 55(2):131\u2013137. https:\/\/doi.org\/10.1007\/s00592-017-1070-2","journal-title":"Acta Diabetol"},{"issue":"12","key":"5354_CR14","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.2337\/dc18-0917","volume":"41","author":"D Ehrmann","year":"2018","unstructured":"Ehrmann D, Kulzer B, Schipfer M, Lippmann-Grob B, Haak T, Hermanns\n                    N (2018) Efficacy of an education program for people with diabetes and insulin\n                    pump treatment (INPUT): results from a randomized controlled trial. Diabetes\n                    Care 41(12):2453\u20132462. https:\/\/doi.org\/10.2337\/dc18-0917","journal-title":"Diabetes Care"},{"issue":"4","key":"5354_CR15","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2337\/diacare.24.4.637","volume":"24","author":"DJ Cox","year":"2001","unstructured":"Cox DJ, Gonder-Frederick L, Polonsky W, Schlundt D, Kovatchev B,\n                    Clarke W (2001) Blood glucose awareness training (BGAT-2): long-term benefits.\n                    Diabetes Care 24(4):637\u2013642. https:\/\/doi.org\/10.2337\/diacare.24.4.637","journal-title":"Diabetes Care"},{"issue":"3","key":"5354_CR16","doi-asserted-by":"publisher","first-page":"863","DOI":"10.2337\/dc13-1245","volume":"37","author":"N de Zoysa","year":"2014","unstructured":"de Zoysa N, Rogers H, Stadler M et al (2014) Psychoeducational\n                    program to restore hypoglycemia awareness: the DAFNE-HART pilot study. Diabetes\n                    Care 37(3):863\u2013866. https:\/\/doi.org\/10.2337\/dc13-1245","journal-title":"Diabetes Care"},{"key":"5354_CR17","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/dom.13963","volume":"22","author":"DR Owens","year":"2020","unstructured":"Owens DR, Bolli GB (2020) The continuing quest for better\n                    subcutaneously administered prandial insulins: a review of recent developments\n                    and potential clinical implications. Diabetes Obes Metab 22:743\u2013754. https:\/\/doi.org\/10.1111\/dom.13963","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"5354_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s40262-019-00834-5","volume":"59","author":"H Haahr","year":"2020","unstructured":"Haahr H, Heise T (2020) Fast-acting insulin aspart: a review of its\n                    pharmacokinetic and pharmacodynamic properties and the clinical consequences.\n                    Clin Pharmacokinet 59(2):155\u2013172. https:\/\/doi.org\/10.1007\/s40262-019-00834-5","journal-title":"Clin Pharmacokinet"},{"key":"5354_CR19","doi-asserted-by":"publisher","unstructured":"Linnebjerg H, Zhang Q, LaBell E et al (2020) Pharmacokinetics and\n                    glucodynamics of ultra rapid lispro (URLi) versus Humalog \u00ae (Lispro) in younger\n                    adults and elderly patients with type 1 diabetes mellitus: a randomised\n                    controlled trial. Clin Pharmacokinet. https:\/\/doi.org\/10.1007\/s40262-020-00903-0","DOI":"10.1007\/s40262-020-00903-0"},{"issue":"9","key":"5354_CR20","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1111\/dom.13798","volume":"21","author":"M Evans","year":"2019","unstructured":"Evans M, Ceriello A, Danne T et al (2019) Use of fast-acting\n                    insulin aspart in insulin pump therapy in clinical practice. Diabetes Obes Metab\n                    21(9):2039\u20132047. https:\/\/doi.org\/10.1111\/dom.13798","journal-title":"Diabetes Obes Metab"},{"key":"5354_CR21","doi-asserted-by":"publisher","unstructured":"Bode B, Garg S, Norwood P et al (2020) Compatibility and safety of\n                    ultra rapid lispro with continuous subcutaneous insulin infusion in patients\n                    with type 1 diabetes: PRONTO-Pump study. Diabetes Technol Ther. https:\/\/doi.org\/10.1089\/dia.2020.0224","DOI":"10.1089\/dia.2020.0224"},{"issue":"6","key":"5354_CR22","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.2337\/diabetes.53.6.1614","volume":"53","author":"T Heise","year":"2004","unstructured":"Heise T, Nosek L, R\u00f8nn BB et al (2004) Lower within-subject\n                    variability of insulin detemir in comparison to NPH insulin and insulin glargine\n                    in people with type 1 diabetes. Diabetes. 53(6):1614\u20131620. https:\/\/doi.org\/10.2337\/diabetes.53.6.1614","journal-title":"Diabetes."},{"issue":"5","key":"5354_CR23","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2337\/diacare.23.5.639","volume":"23","author":"RE Ratner","year":"2000","unstructured":"Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE, Wilson CA\n                    (2000) Less hypoglycemia with insulin glargine in intensive insulin therapy for\n                    type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.\n                    Diabetes Care 23(5):639\u2013643. https:\/\/doi.org\/10.2337\/diacare.23.5.639","journal-title":"Diabetes Care"},{"issue":"7","key":"5354_CR24","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1464-5491.2006.01862.x","volume":"23","author":"K Kolendorf","year":"2006","unstructured":"Kolendorf K, Ross GP, Pavlic-Renar I et al (2006) Insulin detemir\n                    lowers the risk of hypoglycaemia and provides more consistent plasma glucose\n                    levels compared with NPH insulin in type 1 diabetes. Diabet Med 23(7):729\u2013735. https:\/\/doi.org\/10.1111\/j.1464-5491.2006.01862.x","journal-title":"Diabet Med"},{"issue":"11","key":"5354_CR25","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.2337\/diacare.26.11.3080","volume":"26","author":"MC Riddle","year":"2003","unstructured":"Riddle MC, Rosenstock J, Gerich J (2003) The treat-to-target trial:\n                    randomized addition of glargine or human NPH insulin to oral therapy of type 2\n                    diabetic patients. Diabetes Care 26(11):3080\u20133086. https:\/\/doi.org\/10.2337\/diacare.26.11.3080","journal-title":"Diabetes Care"},{"issue":"1","key":"5354_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1179\/acb.2009.009","volume":"64","author":"V Preumont","year":"2009","unstructured":"Preumont V, Buysschaert M, De Beukelaer S, Mathieu C (2009) Insulin\n                    detemir in routine clinical practice: a 26-week follow-up in type 1 diabetic\n                    patients from the Belgian PREDICTIVE Cohort. Acta Clin Belg\n                    64(1):49\u201355","journal-title":"Acta Clin Belg"},{"issue":"1","key":"5354_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2174\/157339911794273892","volume":"7","author":"RF Pollock","year":"2011","unstructured":"Pollock RF, Erny-Albrecht KM, Kalsekar A, Bruhn D, Valentine WJ\n                    (2011) Long-acting insulin analogs: a review of \u201creal-world\u201d effectiveness in\n                    patients with type 2 diabetes. Curr Diabetes Rev 7(1):61\u201374. https:\/\/doi.org\/10.2174\/157339911794273892","journal-title":"Curr Diabetes Rev"},{"issue":"1","key":"5354_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.12782","volume":"19","author":"T Heise","year":"2017","unstructured":"Heise T, Mathieu C (2017) Impact of the mode of protraction of\n                    basal insulin therapies on their pharmacokinetic and pharmacodynamic properties\n                    and resulting clinical outcomes. Diabetes Obes Metab 19(1):3\u201312. https:\/\/doi.org\/10.1111\/dom.12782","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"5354_CR29","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/dme.13891","volume":"37","author":"S Misra","year":"2020","unstructured":"Misra S, Mathieu C (2020) Are newer insulin analogues better for\n                    people with type 1 diabetes? Diabet Med 37(4):522\u2013531. https:\/\/doi.org\/10.1111\/dme.13891","journal-title":"Diabet Med"},{"issue":"3","key":"5354_CR30","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00592-018-1258-0","volume":"56","author":"A D\u00edez-Fern\u00e1ndez","year":"2019","unstructured":"D\u00edez-Fern\u00e1ndez A, Cavero-Redondo I, Moreno-Fern\u00e1ndez J,\n                    Pozuelo-Carrascosa DP, Garrido-Miguel M, Mart\u00ednez-Vizca\u00edno V (2019)\n                    Effectiveness of insulin glargine U-300 versus insulin glargine U-100 on\n                    nocturnal hypoglycemia and glycemic control in type 1 and type 2 diabetes: a\n                    systematic review and meta-analysis. Acta Diabetol 56(3):355\u2013364. https:\/\/doi.org\/10.1007\/s00592-018-1258-0","journal-title":"Acta Diabetol"},{"issue":"7","key":"5354_CR31","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/dme.13976","volume":"36","author":"ST Knudsen","year":"2019","unstructured":"Knudsen ST, Lapolla A, Schultes B et al (2019) Clinical benefits of\n                    switching to insulin degludec irrespective of previous basal insulin therapy in\n                    people with type 1 or type 2 diabetes: evidence from a European, multicentre,\n                    retrospective, non-interventional study (EU-TREAT). Diabet Med 36(7):868\u2013877. https:\/\/doi.org\/10.1111\/dme.13976","journal-title":"Diabet Med"},{"issue":"3","key":"5354_CR32","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1210\/jc.2012-3249","volume":"98","author":"C Mathieu","year":"2013","unstructured":"Mathieu C, Hollander P, Miranda-Palma B et al (2013) Efficacy and\n                    safety of insulin degludec in a flexible dosing regimen vs insulin glargine in\n                    patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized,\n                    treat-to-target trial with a 26-week extension. J Clin Endocrinol Metab\n                    98(3):1154\u20131162. https:\/\/doi.org\/10.1210\/jc.2012-3249","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"5354_CR33","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1210\/jc.2017-02498","volume":"103","author":"S Charleer","year":"2018","unstructured":"Charleer S, Mathieu C, Nobels F et al (2018) Effect of continuous\n                    glucose monitoring on glycemic control, acute admissions, and quality of life: a\n                    real-world study. J Clin Endocrinol Metab 103(3):1224\u20131232. https:\/\/doi.org\/10.1210\/jc.2017-02498","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"5354_CR34","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.2337\/dc13-0939","volume":"36","author":"P Choudhary","year":"2013","unstructured":"Choudhary P, Ramasamy S, Green L et al (2013) Real-time continuous\n                    glucose monitoring significantly reduces severe hypoglycemia in\n                    hypoglycemia-unaware patients with type 1 diabetes. Diabetes Care\n                    36(12):4160\u20134162. https:\/\/doi.org\/10.2337\/dc13-0939","journal-title":"Diabetes Care"},{"issue":"1","key":"5354_CR35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ecl.2019.10.007","volume":"49","author":"CK Boughton","year":"2020","unstructured":"Boughton CK, Hovorka R (2020) Automated insulin delivery in adults.\n                    Endocrinol Metab Clin N Am 49(1):167\u2013178. https:\/\/doi.org\/10.1016\/j.ecl.2019.10.007","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"12","key":"5354_CR36","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.2337\/dci15-0002","volume":"38","author":"JL Leahy","year":"2015","unstructured":"Leahy JL (2015) Technosphere inhaled insulin: is faster better?\n                    Diabetes Care 38(12):2282\u20132284. https:\/\/doi.org\/10.2337\/dci15-0002","journal-title":"Diabetes Care"},{"key":"5354_CR37","doi-asserted-by":"crossref","unstructured":"Buse JB, Wexler DJ, Tsapas A et al (2020) 2019 update to:\n                    Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the\n                    American Diabetes Association (ADA) and the European Association for the Study\n                    of Diabetes (EASD). Diabetologia (63):221\u2013228","DOI":"10.1007\/s00125-019-05039-w"},{"issue":"12","key":"5354_CR38","doi-asserted-by":"publisher","first-page":"107473","DOI":"10.1016\/j.jdiacomp.2019.107473","volume":"33","author":"J David","year":"2019","unstructured":"David J, Fonseca V (2019) When should fixed ratio basal\n                    insulin\/glucagon-like peptide-1 receptor agonists combination products be\n                    considered? J Diabetes Complicat 33(12):107473. https:\/\/doi.org\/10.1016\/j.jdiacomp.2019.107473","journal-title":"J Diabetes Complicat"},{"issue":"10","key":"5354_CR39","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/1753-0407.13078","volume":"12","author":"I Goyal","year":"2020","unstructured":"Goyal I, Sattar A, Johnson M, Dandona P (2020) Adjunct therapies in\n                    treatment of type 1 diabetes. J Diabetes 12(10):742\u2013753. https:\/\/doi.org\/10.1111\/1753-0407.13078","journal-title":"J Diabetes"},{"key":"5354_CR40","doi-asserted-by":"publisher","unstructured":"Mathieu C, Dandona P, Birkenfeld AL et al (2020) Benefit\/risk\n                    profile of dapagliflozin 5 mg in the DEPICT-1 and -2 trials in individuals with\n                    type 1 diabetes and body mass index \u226527 kg\/m2.\n                    Diabetes Obes Metab. https:\/\/doi.org\/10.1111\/dom.14144","DOI":"10.1111\/dom.14144"},{"key":"5354_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2042018820938545","volume":"11","author":"B Janssens","year":"2020","unstructured":"Janssens B, Caerels S, Mathieu C (2020) SGLT inhibitors in type 1\n                    diabetes: weighing efficacy and side effects. Ther Adv Endocrinol Metab\n                    11:1\u201310","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"4","key":"5354_CR42","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S2213-8587(20)30043-7","volume":"8","author":"MA Nauck","year":"2020","unstructured":"Nauck MA, Meier JJ (2020) GLP-1 receptor agonists in type 1\n                    diabetes: a MAG1C bullet? Lancet Diabetes Endocrinol 8(4):262\u2013264. https:\/\/doi.org\/10.1016\/S2213-8587(20)30043-7","journal-title":"Lancet Diabetes Endocrinol"},{"key":"5354_CR43","doi-asserted-by":"publisher","unstructured":"Rosenstock J, Bajaj HS, Jane\u017e A et al (2020) Once-weekly insulin\n                    for type 2 diabetes without previous insulin treatment. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2022474","DOI":"10.1056\/NEJMoa2022474"},{"issue":"8","key":"5354_CR44","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/S2213-8587(15)00097-2","volume":"3","author":"A Cahn","year":"2015","unstructured":"Cahn A, Miccoli R, Dardano A, Del Prato S (2015) New forms of\n                    insulin and insulin therapies for the treatment of type 2 diabetes. Lancet\n                    Diabetes Endocrinol 3(8):638\u2013652. https:\/\/doi.org\/10.1016\/S2213-8587(15)00097-2","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"5354_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s13300-016-0214-7","volume":"8","author":"A Mu\u00f1oz-Garach","year":"2017","unstructured":"Mu\u00f1oz-Garach A, Molina-Vega M, Tinahones FJ (2017) How can a good\n                    idea fail? Basal insulin peglispro [LY2605541] for the treatment of type 2\n                    diabetes. Diabetes Ther 8(1):9\u201322. https:\/\/doi.org\/10.1007\/s13300-016-0214-7","journal-title":"Diabetes Ther"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-020-05354-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-020-05354-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-020-05354-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T20:03:34Z","timestamp":1642277014000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-020-05354-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,16]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["5354"],"URL":"https:\/\/doi.org\/10.1007\/s00125-020-05354-7","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,16]]},"assertion":[{"value":"5 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}